ACTU Actuate Therapeutics, Inc.

NASDAQ

$0.33

Actuate Therapeutics, Inc. (ACTU) Earnings News

Earnings press releases, previews and reviews for Actuate Therapeutics, Inc. (ACTU), newest first.